Literature DB >> 35308745

Pancreatic Pseudocysts as a Late Manifestation of COVID-19.

Valeria Hinojosa1, Elizabeth Gamboa2, Joseph Varon3,4,5.   

Abstract

The novel coronavirus disease has caused an ongoing pandemic since the end of 2019. It is a transmissible infection caused by the SARS-CoV-2 virus. The highly infectious nature of this illness is based mostly throughout the respiratory tract. However, this virus can affect all systems of the human body, such as the gastrointestinal tract. We report a case of pancreatic pseudocysts as a late manifestation of COVID-19.
Copyright © 2022, Hinojosa et al.

Entities:  

Keywords:  coronavirus disease; covid-19; pancreatitis; pneumonia; pseudocyst

Year:  2022        PMID： 35308745      PMCID： PMC8923726          DOI： 10.7759/cureus.22181

Source DB:  PubMed          Journal:  Cureus        ISSN： 2168-8184


  9 in total

Review 1.  Pancreatic pseudocyst.

Authors:  Samir Habashi; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

Review 2.  COVID-19: immunopathogenesis and Immunotherapeutics.

Authors:  Li Yang; Shasha Liu; Jinyan Liu; Zhixin Zhang; Xiaochun Wan; Bo Huang; Youhai Chen; Yi Zhang
Journal:  Signal Transduct Target Ther       Date:  2020-07-25

3.  The COVID-19 epidemic.

Authors:  Thirumalaisamy P Velavan; Christian G Meyer
Journal:  Trop Med Int Health       Date:  2020-02-16       Impact factor: 2.622

4.  SARS-CoV2 RNA detection in a pancreatic pseudocyst sample.

Authors:  T Schepis; A Larghi; A Papa; L Miele; F Panzuto; L De Biase; B Annibale; P Cattani; G L Rapaccini
Journal:  Pancreatology       Date:  2020-05-28       Impact factor: 3.977

5.  Pancreatic injury in the course of coronavirus disease 2019: A not-so-rare occurrence.

Authors:  Giuseppe Bruno; Claudia Fabrizio; Carmen R Santoro; Giovanni B Buccoliero
Journal:  J Med Virol       Date:  2020-06-29       Impact factor: 20.693

6.  COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease.

Authors:  Rosemary Gan; Nicholas P Rosoman; David J E Henshaw; Euan P Noble; Peter Georgius; Nigel Sommerfeld
Journal:  Med Hypotheses       Date:  2020-06-23       Impact factor: 1.538

7.  ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection.

Authors:  Furong Liu; Xin Long; Bixiang Zhang; Wanguang Zhang; Xiaoping Chen; Zhanguo Zhang
Journal:  Clin Gastroenterol Hepatol       Date:  2020-04-22       Impact factor: 11.382

Review 8.  Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).

Authors:  Arno R Bourgonje; Amaal E Abdulle; Wim Timens; Jan-Luuk Hillebrands; Gerjan J Navis; Sanne J Gordijn; Marieke C Bolling; Gerard Dijkstra; Adriaan A Voors; Albert Dme Osterhaus; Peter Hj van der Voort; Douwe J Mulder; Harry van Goor
Journal:  J Pathol       Date:  2020-06-10       Impact factor: 9.883
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.